FDA approves a new treatment for macular degeneration: the good, the bad, and the disappointing.
I've been seeing a pattern of deceptive videos that promise to reveal a secret but make you watch the entire video to learn what it is. They feature alarmist stories, emotional language, and testimonials, but no actual science. They make claims that can't be believed.
Is genetic testing necessary to optimize treatment for patients with a potentially blinding eye disease? The stakes are high and the answer depends on which of the two feuding, financially-conflicted groups you believe. In the end, the best evidence wins!
Three patients were treated with a slurry of stem cells and blood products, in both eyes, on the same day. Could the outcome, three patients becoming legally blind, have been foreseen? Probably.
Rigorous scientists stabilized a patient’s macular degeneration with a cutting-edge stem cell treatment; less rigorous scientists misapplied stem cell science and left three women blind.
After the AREDS trial, people with moderate to severe age-related macular degeneration were advised to take dietary supplements to slow the progression of the disease. But some experts say the trial actually showed supplements don't work, and might even make some patients worse.
This post is dedicated to two people who are frequent commenters on SBM, Stephen S. Rodrigues and Peter Moran. Rodrigues is an MD/acupuncturist who tries to persuade us that acupuncture is effective. Moran is a retired surgeon who objects to insulting language and thinks more can be accomplished by trying to better understand why people turn to CAM and by explaining the...
Four years ago I wrote about the premature marketing of a diet supplement for macular degeneration before the results of a trial to test it were available. Now that we know the results of that trial, a follow-up post is in order. Age-related macular degeneration (AMD) is a leading cause of blindness. The incidence increases with age; it affects 10% of people...